The Valley Desk

NCT06241118 · Interventional trial

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor

Overall registry status Active not recruiting

Phase 3

Conditions Dermatitis Atopic

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov